A novel integrated miRNA–donor age signature enables detection of cardiac allograft vasculopathy

Irene González-Torrent; Carlota Benedicto; Marta Delgado-Arija; Lorena Pérez-Carrillo; Isaac Giménez-Escamilla; Estefanía Tarazón; Esther Roselló-Lletí

doi:10.1002/ctm2.70636

Clinical and Translational Medicine ›› 2026, Vol. 16 ›› Issue (3) :e70636 DOI: 10.1002/ctm2.70636

LETTER TO THE JOURNAL

A novel integrated miRNA–donor age signature enables detection of cardiac allograft vasculopathy

Author information +

History +

PDF (749KB)

Cite this article

Download citation ▾

Irene González-Torrent, Carlota Benedicto, Marta Delgado-Arija, Lorena Pérez-Carrillo, Isaac Giménez-Escamilla, Estefanía Tarazón, Esther Roselló-Lletí. A novel integrated miRNA–donor age signature enables detection of cardiac allograft vasculopathy. Clinical and Translational Medicine, 2026, 16 (3) : e70636 DOI:10.1002/ctm2.70636

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Nikolova AP, Kobashigawa JA. Cardiac allograft vasculopathy: the enduring enemy of cardiac transplantation. Transplantation. 2019; 103(7): 1338-1348.

[2]	Spartalis M, Spartalis E, Siasos G. Cardiac allograft vasculopathy after heart transplantation: pathophysiology, detection approaches, prevention, and treatment management. Trends Cardiovasc Med. 2022; 32(6): 333-338.

[3]	O'Hara PE, Gorrai A, Farr M, et al. Revisiting biomarkers of cardiac allograft vasculopathy: addressing the Achilles heel of heart transplantation. Curr Heart Fail Rep. 2024; 21(6): 580-590.

[4]	Van Dijk BCJ, Bos D, Roest S, et al. Coronary computed tomography angiography in heart transplant patients: current insights and future directions. Transplantation. 2025; 109(6): 945.

[5]	Pérez-Carrillo L, Sánchez-Lázaro I, Triviño JC, et al. Combining serum miR-144-3p and miR-652-3p as potential biomarkers for the early diagnosis and stratification of acute cellular rejection in heart transplantation patients. Transplantation. 2023; 107(9): 2064.

[6]	Nagji AS, Hranjec T, Swenson BR, et al. Donor age is associated with chronic allograft vasculopathy after adult heart transplantation: implications for donor allocation. Ann Thorac Surg. 2010; 90(1): 168.

[7]

Khush KK, Cherikh WS, Chambers DC, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-sixth adult heart transplantation report — 2019; focus theme: donor and recipient size match. J Heart Lung Transplantation. 2019; 38(10): 1056-1066.

[8]	Macrae DJ. The Council for International Organizations and Medical Sciences (CIOMS) guidelines on ethics of clinical trials. Proc Am Thorac Soc. 2007; 4(2): 176-178.

RIGHTS & PERMISSIONS

2026 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.